Thus, the analysis of the expression of estrogen receptors, progesterone, human epidermal growth factor 2 (HER2) and the Ki-67 proliferative activity index determines the well-known molecular subtypes of breast cancer [10]. This evidence concerns the gene ERBB2 and breast carcinoma.